Replies to post #35162 on PharmaCyte Biotech Inc (PMCB)

[LuCo]

Then you have to admit promoters and longs have an agenda. Some longs say it's "possible" that PMCB could be buying shares back, talking out of their arse.

I have yet to see a long discuss the flaws on PMCB. Not enough room for that I guess.

And since I can only post once a day I'm going to post the newest extension of the KW agreement via most recent 8k

"As previously disclosed, subject to Mr. Waggoner entering into the Waggoner Compensation Agreement, in March of 2014, the Board granted Mr. Waggoner 10,000,000 shares of our Common Stock. On March 11, 2015, Mr. Waggoner was granted 2,400,000 shares of Common Stock vesting at the rate of 600,000 shares per quarter with an identical grant to be made on January 1, 2016. Further, as previously disclosed, subject to Mr. Waggoner entering into the Waggoner Compensation Agreement, on March 11, 2015, Mr. Waggoner was granted a stock option to purchase up to 10,000,000 shares of Common Stock at a price of $0.11 per share, the fair market value on the date of grant, and on March 11, 2015, was granted a second stock option to purchase up to 2,400,000 shares at a price of $0.11 per share, the fair market value on the date of grant, with vesting at the rate of 200,000 shares per month. On January 1, 2016, Mr. Waggoner will be granted another stock option to purchase up to 2,400,000 shares at the fair market value on the date of grant with the same vesting schedule."

Could the drop in price to .11 have any relation to KWs "fair" share price entry?

Also via recent 8k

Out of the 9.3 million dollars in expenses
7.5 of that was compensation/salary expenses.